Four More Reasons Why Investors Should Nix The Pfizer-Allergan Merger

In January 1999, as big pharma was rocked by several mergers, Pfizer’s CEO William Steere dismissed them, claiming that “mergers in this industry are done out of weakness… We’re not weak”. Later that year, he ate these words, arguing instead that Pfizer should buy Warner-Lambert because this merger was done […]

Source: Forbes – Forbes – Management.


Published by

Shawn Boday

Shawn Boday is the Founder and President of Perday LLC, a real estate investment company based in Seattle, WA. In his free time Shawn enjoys snowboarding, water sports, philanthropic endeavors, and traveling.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s